Sectra, Synthetic MR ink distribution agreement

Sectra and Synthetic MR have signed a distribution agreement for Synthetic’s software-based technology for MR exam analysis.

In accordance with the agreement, the Linköping, Sweden-based Sectra said it will distribute Synthetic’s software, SyMRI Suite, as a plug-in to its PACS system.

With Synthetic’s software as part of it PACS, Sectra said it will increase not only the efficiency of the actual MR exams, but also the effectiveness of the radiologists for identifying pathological tissue, according to Torbjörn Kronander, president of Sectra’s medical business.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.